Real-World Experience with FcRn Inhibitors Efgartigimod and Rozanolixizumab in Myasthenia Gravis: Administration in Multiple Cycles and Transition from Intravenous to Subcutaneous FormulationMasaaki Yoshikawa, Haruki Koike, Makoto Eriguchi et al.|Neurology and Therapy|2025Cited by 13
Involvement of the nigrostriatal system in Gerstman–Sträussler–Scheinker disease with the PRNP-P102L mutationNatsuki Ono, Haruki Koike, Kohei Suzuyama et al.|Journal of the Neurological Sciences|2024Cited by 4
The natural history of 32 Japanese cases of Gerstmann-Sträussler-Scheinker along Ariake SeaKohei Suzuyama, Haruki Koike, Masaaki Yoshikawa et al.|Journal of the Neurological Sciences|2025Cited by 0
Involvement of the nigrostriatal system in Gerstman–Sträussler–Scheinker disease with the PRNP-P102L mutationNatsuki Ono, Haruki Koike, Kohei Suzuyama et al.|Journal of the Neurological Sciences|2025Cited by 0